Hong Zeng

Title: Innovations and Contributions of Inventor Hong Zeng

Introduction

Hong Zeng is a prominent inventor based in Chengdu, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibody-drug conjugates. With a total of 11 patents to his name, Zeng's work has the potential to impact cancer treatment and prevention.

Latest Patents

Among his latest patents is the "Anti-ErbB2 antibody-drug conjugate and composition thereof, preparation method therefor, and use thereof." This patent provides a preparation method for an antibody-drug conjugate, which is crucial for targeted cancer therapies. Another notable patent is the "Pharmaceutical composition for tumor treatment or prevention, method, and use thereof." This patent involves a pharmaceutical composition that includes a 4'-thionucleoside phosphamide derivative, which can be used in various treatment methods for diseases.

Career Highlights

Hong Zeng has worked with notable companies in the biopharmaceutical sector, including Sichuan Kelun Biotech Biopharmaceutical Co., Ltd. and Sichuan Keiun Biotech Biopharmaceutical Co., Ltd. His experience in these organizations has allowed him to develop innovative solutions in drug formulation and delivery.

Collaborations

Zeng has collaborated with several professionals in his field, including Lichun Wang and Jingyi Wang. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Hong Zeng's contributions to the field of biopharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment and prevention.